Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease

Chinese Medical Journal

Volumn 127, Issue 14, 2014, Pages 2594-2598

  Zhang, Rong Bao ^a   Tan, Xing Yu ^a   He, Quan Ying ^a   Chen, Qing ^a   Gai, Jun ^a   Wei, Jing An ^a   Wang, Yan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Exacerbation; Lung function tests

Indexed keywords

SALBUTAMOL;

AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; COPD ASSESSMENT TEST; DIAGNOSTIC ACCURACY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED BRITISH MEDICAL RESEARCH COUNCIL SCALE; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

DYSPNEA; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT;

EID: 84904419710     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20133317     Document Type: Article

References (20)

1. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what? Clin Respir J 2012; 6: 208-214.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
3. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
4. COPD Group, Chinese Society of Respiratory Diseases. Chinese Guidelines for the Diagnosis and Management of Chronic Obstructive Pulmonary Disease (Revised 2007) (in Chinese). Chin J Tuberc Respir Dis 2007; 30: 8-17.
5. Zhang RB, Tan XY, He QY, Chen Q, Gai J, Wei JA, et al. Intervention effects of different management modes on patients with chronic obstructive pulmonary disease (in Chinese). Natl Med J China 2012; 92: 3117-3121.
6. The Asthma Group, Chinese Society of Respiratory Diseases. Chinese Guideline for Management of Bronchial Asthma (the definition, diagnosis, treatment and management of bronchial asthma) (in Chinese). Chin J Tuberc Respir Dis 2008; 31: 177-185.
7. Liu T, Cai BQ. A new health-related quality of life questionnaire: chronic obstructive pulmonary disease assessment test (CAT) (in Chinese). ACTA Academiae Medicinae Sinicae 2010; 32: 234-238.
8. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
9. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011; 38: 29-35.
10. Dodd JW, Marns PL, Clark AL, Ingram KA, Fowler RP, Canavan JL, et al. The COPD Assessment Test (CAT): short-and medium-term response to pulmonary rehabilitation. COPD 2012; 9: 390-394
11. Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest 2012; 142: 134-140.
12. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012; 185: 1218-1224.
13. Jones P, Adamek L, Nadeau G, Banik N. Comparison of modified Medical Research Council (mMRC) dyspnoea scale cut point ≥1 with COPD assessment test (CAT) ≥10 to differentiate low and high symptom COPD patients. Paper presented at: 22nd European respiratory annual congress; September 1-5, 2012; Vienna, Austria. Abstract: 1651.
14. Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, et al. GOLD 2011 disease severity classification in COPD Gene: a prospective cohort study. Lancet Respir Med 2013; 1: 43-50.
15. Weatherall M, Marsh S, Shirtcliffe P, Williams M, Travers J, Beasley R. Quality of life measured by the St. George's Respiratory Questionnaire and spirometry. Eur Respir J 2009; 33: 1025-1030.
16. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.
17. Redelmeier DA, Goldstein RS, Min ST, Hyland RH. Spirometry and dyspnea in patients with COPD. When small differences mean little. Chest 1996; 109: 1163-1168
18. Liang L, Lin Y, Yang T, Zhang H, Li J, Wang C. Determinants of health-related quality of life worsening in patients with chronic obstructive pulmonary disease at one year. Chin Med J 2014; 127: 4-10.
19. Anthonisen NR, Manfreda J, Warren CP, Hershfeld ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
20. Mackay A, Donaldson G, Patel A, Singh R, Hurst J, Wedzicha J. Combined COPD assessment using the new GOLD guidelines. Paper presented at: 22nd European respiratory annual congress; September 1-5, 2012; Vienna, Austria. Abstract: 1647.